Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
$128.77
+1.3%
$123.32
$110.44
$199.85
$39.53B1.373.10 million shs4.09 million shs
Energy Transfer LP stock logo
ET
Energy Transfer
$18.21
+0.1%
$17.58
$14.60
$21.45
$62.46B0.7815.77 million shs13.73 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$24.20
-0.2%
$23.46
$20.92
$31.54
$137.53B0.5741.37 million shs39.50 million shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
0.00%+3.70%+9.00%+2.30%-8.21%
Energy Transfer LP stock logo
ET
Energy Transfer
0.00%+2.25%+3.03%-2.73%+14.35%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%+0.95%+3.23%-3.99%-11.76%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
4.955 of 5 stars
3.25.04.22.03.02.52.5
Energy Transfer LP stock logo
ET
Energy Transfer
3.7664 of 5 stars
2.54.01.70.02.80.83.1
Pfizer Inc. stock logo
PFE
Pfizer
4.8657 of 5 stars
2.33.04.24.32.91.73.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
2.40
Hold$151.1517.38% Upside
Energy Transfer LP stock logo
ET
Energy Transfer
2.91
Moderate Buy$22.6424.34% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.53
Moderate Buy$29.1720.54% Upside

Current Analyst Ratings Breakdown

Latest DHI, ET, and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/20/2025
Energy Transfer LP stock logo
ET
Energy Transfer
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$22.00 ➝ $23.00
5/19/2025
Energy Transfer LP stock logo
ET
Energy Transfer
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$25.00 ➝ $23.00
5/7/2025
Energy Transfer LP stock logo
ET
Energy Transfer
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$22.00 ➝ $21.00
4/30/2025
Pfizer Inc. stock logo
PFE
Pfizer
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$24.00 ➝ $25.00
4/22/2025
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Perform ➝ Market Perform$165.00 ➝ $135.00
4/22/2025
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight ➝ Neutral$24.00
4/21/2025
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderperform ➝ Underperform$125.00 ➝ $105.00
4/21/2025
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$132.00 ➝ $111.00
4/21/2025
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$210.00 ➝ $180.00
4/21/2025
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$120.00 ➝ $110.00
4/17/2025
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral$150.00 ➝ $125.00
(Data available from 6/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
$36.80B1.07$14.87 per share8.66$79.25 per share1.62
Energy Transfer LP stock logo
ET
Energy Transfer
$82.67B0.76$2.79 per share6.52$12.31 per share1.48
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.16$4.37 per share5.54$15.62 per share1.55
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
$4.76B$13.219.758.924.0212.15%16.95%12.09%7/22/2025 (Estimated)
Energy Transfer LP stock logo
ET
Energy Transfer
$4.45B$1.3213.7911.980.595.88%11.47%3.88%8/6/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.3817.537.990.8812.62%20.33%8.53%8/5/2025 (Estimated)

Latest DHI, ET, and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/22/2025Q3 2025
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
$2.93N/AN/AN/A$8.80 billionN/A
5/6/2025Q1 2025
Energy Transfer LP stock logo
ET
Energy Transfer
$0.33$0.36+$0.03$0.36$22.28 billion$21.02 billion
4/29/2025Q1 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.67$0.92+$0.25$0.52$14.43 billion$13.72 billion
4/17/2025Q2 2025
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
$2.69$2.58-$0.11$2.58$8.07 billion$7.73 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
$1.601.24%N/A12.11%10 Years
Energy Transfer LP stock logo
ET
Energy Transfer
$1.317.20%N/A99.24%4 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.727.11%N/A124.64%16 Years

Latest DHI, ET, and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/25/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.08%7/25/20257/25/20259/2/2025
4/23/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.69%5/9/20255/9/20256/13/2025
4/24/2025
Energy Transfer LP stock logo
ET
Energy Transfer
quarterly$0.32757.5%5/9/20255/9/20255/20/2025
4/21/2025
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
quarterly$0.401.3%5/2/20255/2/20255/9/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
0.26
7.29
1.15
Energy Transfer LP stock logo
ET
Energy Transfer
1.41
1.12
0.92
Pfizer Inc. stock logo
PFE
Pfizer
0.64
1.26
0.96

Institutional Ownership

CompanyInstitutional Ownership
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
90.63%
Energy Transfer LP stock logo
ET
Energy Transfer
38.22%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
0.54%
Energy Transfer LP stock logo
ET
Energy Transfer
3.28%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
CompanyEmployeesShares OutstandingFree FloatOptionable
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
14,766307.18 million305.52 millionOptionable
Energy Transfer LP stock logo
ET
Energy Transfer
16,2483.43 billion3.32 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
81,0005.69 billion5.68 billionOptionable

Recent News About These Companies

Perpetual Ltd Grows Stake in Pfizer Inc. (NYSE:PFE)
5 Recession-Proof Dividend Stocks With Yields Over 6%

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
D.R. Horton stock logo

D.R. Horton NYSE:DHI

$128.77 +1.62 (+1.27%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$128.75 -0.02 (-0.01%)
As of 06/27/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

D.R. Horton, Inc. operates as a homebuilding company in East, North, Southeast, South Central, Southwest, and Northwest regions in the United States. It engages in the acquisition and development of land; and construction and sale of residential homes in 118 markets across 33 states under the names of D.R. Horton, America's Builder, Express Homes, Emerald Homes, and Freedom Homes. The company constructs and sells single-family detached homes; and attached homes, such as townhomes, duplexes, and triplexes. It also provides mortgage financing services; and title insurance policies, and examination and closing services, as well as engages in the residential lot development business. In addition, the company develops, constructs, owns, leases, and sells multi-family and single-family rental properties; and owns non-residential real estate, including ranch land and improvements. It primarily serves homebuyers. D.R. Horton, Inc. was founded in 1978 and is headquartered in Arlington, Texas.

Energy Transfer stock logo

Energy Transfer NYSE:ET

$18.20 +0.03 (+0.14%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$18.18 -0.02 (-0.14%)
As of 06/27/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Energy Transfer LP provides energy-related services. The company owns and operates natural gas transportation pipeline, and natural gas storage facilities in Texas and Oklahoma; and approximately 20,090 miles of interstate natural gas pipeline. It also sells natural gas to electric utilities, independent power plants, local distribution and other marketing companies, and industrial end-users. In addition, the company owns and operates natural gas gathering pipelines, processing plant, and treating and conditioning facilities in Texas, New Mexico, West Virginia, Pennsylvania, Ohio, Oklahoma, Arkansas, Kansas, Montana, North Dakota, Wyoming, and Louisiana; natural gas gathering, oil pipeline, and oil stabilization facilities in South Texas; and transports and supplies water to natural gas producer in Pennsylvania. Further, it owns 5,700 miles of natural gas liquid (NGL) pipeline; NGL fractionation facilities; NGL storage facilities; and other NGL storage assets and terminal. Additionally, the company provides crude oil transportation, terminalling, acquisition, and marketing activities; owns and operates approximately 14,500 miles of crude oil trunk and gathering pipelines in the Southwest, Midcontinent, and Midwest United States; and sells and distributes gasoline, middle distillate, and motor fuels and other petroleum products. It also offers natural gas compression services; carbon dioxide and hydrogen sulfide removal services; and manages coal and natural resources properties, as well as sells standing timber, leases coal-related infrastructure facilities, collects oil and gas royalty, and generate electrical power. The company was formerly known as Energy Transfer Equity, L.P. and changed its name to Energy Transfer LP in October 2018. Energy Transfer LP was founded in 1996 and is headquartered in Dallas, Texas.

Pfizer stock logo

Pfizer NYSE:PFE

$24.20 -0.04 (-0.18%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$24.18 -0.02 (-0.07%)
As of 06/27/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.